Literature DB >> 35317357

External validation of risk prediction platforms for pancreatic fistula after pancreatoduodenectomy using nomograms and artificial intelligence.

So Jeong Yoon1, Wooil Kwon2, Ok Joo Lee1, Ji Hye Jung1, Yong Chan Shin3, Chang-Sup Lim4, Hongbeom Kim2, Jin-Young Jang2, Sang Hyun Shin1, Jin Seok Heo1, In Woong Han1.   

Abstract

Purpose: Postoperative pancreatic fistula (POPF) is a life-threatening complication following pancreatoduodenectomy (PD). We previously developed nomogram- and artificial intelligence (AI)-based risk prediction platforms for POPF after PD. This study aims to externally validate these platforms.
Methods: Between January 2007 and December 2016, a total of 1,576 patients who underwent PD in Seoul National University Hospital, Ilsan Paik Hospital, and Boramae Medical Center were retrospectively reviewed. The individual risk scores for POPF were calculated using each platform by Samsung Medical Center. The predictive ability was evaluated using a receiver operating characteristic curve and the area under the curve (AUC). The optimal predictive value was obtained via backward elimination in accordance with the results from the AI development process.
Results: The AUC of the nomogram after external validation was 0.679 (P < 0.001). The values of AUC after backward elimination in the AI model varied from 0.585 to 0.672. A total of 13 risk factors represented the maximal AUC of 0.672 (P < 0.001).
Conclusion: We performed external validation of previously developed platforms for predicting POPF. Further research is needed to investigate other potential risk factors and thereby improve the predictability of the platform.
Copyright © 2022, the Korean Surgical Society.

Entities:  

Keywords:  Artificial intelligence; Nomograms; Pancreatic fistula; Pancreatoduodenectomy; Postoperative complications

Year:  2022        PMID: 35317357      PMCID: PMC8914522          DOI: 10.4174/astr.2022.102.3.147

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


INTRODUCTION

Postoperative pancreatic fistula (POPF) is one of the most fatal complications after pancreatoduodenectomy (PD) and is associated with postoperative hemorrhage, intraabdominal infections, and increased mortality [12]. The incidence of POPF remains high despite advances in surgical techniques and perioperative management [2]. Particularly for clinically relevant POPF (CR-POPF), defined by the grading system of the International Study Group of Pancreatic Fistula (ISGPF) [3], the reported incidence was 14.5% in a previous meta-analysis [4]. Many studies have analyzed the risk factors for POPF. Based on traditional risk factors, there were attempts to develop platforms for predicting POPF [56]. However, due to the limited predictive values of previous platforms [78], we developed new risk prediction platforms using nomograms [9] and artificial intelligence (AI) technology [10]. The nomogram consisting of 6 preoperatively available data provides a better insight into the risk factors and their contributions. The AI model was based on an in-depth analysis of risk factors using machine learning algorithms. The model finally included 16 preoperative and intraoperative variables. Both models are readily available in the form of a calculator at http://popf.smchbp.org and http://popfrisk.smchbp.org. In this study, we performed external validation of the aforementioned platforms with multicenter datasets to verify the reproducibility and generalizability of the models and to determine their clinical utilities.

METHODS

This study was approved by the Institutional Review Boards of Samsung Medical Center (Seoul, Korea; No. 2020-09-181), Seoul National University Hospital (Seoul, Korea; No. SNUH 2010-147-116), Ilsan Paik Hospital (Goyang, Korea; No. 2021-06-009), and Boramae Medical Center (Seoul, Korea; No. 30-2021-72). The study was performed in accordance with the Declaration of Helsinki and written informed consent was waived due to its retrospective nature.

Patient database

The cohort for external validation included 1,576 patients who underwent PD between January 2007 and December 2016 at 3 different centers: Seoul National University Hospital, Ilsan Paik Hospital, and Boramae Medical Center. The patients’ demographic data, preoperative laboratory results, imaging findings and surgical outcomes were retrospectively reviewed.

Perioperative data and risk calculation

The individual risks of CR-POPF were calculated using previously developed nomogram- and AI-based web calculators, which are available at the websites (Fig. 1). The nomogram was based on the following 6 preoperative variables: sex, body mass index (BMI), the American Society of Anesthesiology physical status (ASA PS) classification, serum albumin, tumor location, and the diameter of the main pancreatic duct (MPD) measured via CT or magnetic resonance cholangiopancreatography. The AI calculator was developed using the following preoperative and intraoperative variables: age, sex, BMI, underlying heart disease, ASA PS classification, preoperative platelet count, serum albumin, serum lipase, preoperative endoscopic biliary drainage, neoadjuvant radiotherapy, amount of intraoperative fluid infusion, pancreatic texture, the diameter of MPD, portal vein resection, coexisting pancreatitis detected preoperatively or intraoperatively, and tumor location.
Fig. 1

(A) The web-based nomogram calculator (http://popf.smchbp.org). (B) The web-based artificial intelligence (AI) calculator (http://popfrisk.smchbp.org).

There were no missing values in the categorical variables of the validation cohort. Median imputation was used for the missing continuous variables to replace the missing data with medians.

Postoperative outcomes

POPF was diagnosed and graded according to the 2016 ISGPF definition and grading. POPF grades B and C (CR-POPF) were included as the outcomes in the analysis, and biochemical leak was not counted.

Statistical analysis and external validation

Receiver operating characteristic (ROC) curve analyses were performed using IBM SPSS Statistics ver. 26 (IBM Corp., Armonk, NY, USA). The area under the curve (AUC) for the logistic regression model was reported with 95% confidence intervals (CIs). The AUC values with P-values of less than 0.05 were regarded as statistically significant. Backward elimination was performed to obtain the optimal AUC value of the AI model by selecting features that had no significant prognostic value. The AUC for each model was calculated based on the stepwise selection in accordance with the development process.

RESULTS

The clinical demographics and surgical outcomes of 1,576 patients in the validation cohort are presented in Table 1. The patients’ mean age was 63.6 years, and 697 patients (44.2%) had underlying heart disease including hypertension. Preoperative endoscopic biliary drainage was performed in 825 patients (52.3%). Intraoperatively, 1,056 patients (67.0%) had soft pancreas and the mean diameter of MPD was 3.5 mm. CR-POPF was developed in 270 patients (17.1%).
Table 1

Demographic and clinical characteristics, and surgical outcomes of the validation cohort

Values are presented as number only, mean ± standard deviation, or number (%).

ASA PS, American Society of Anesthesiologist physical status; CCRT, concurrent chemoradiotherapy; POPF, postoperative pancreatic fistula; BCL, biochemical leakage.

a)Data were not available in 1, 688, and 2 patients in order.

In the external validation of the nomogram with 1,576 patients, the ROC curve was drawn with the AUC of 0.679 (95% CI, 0.645–0.713; P < 0.001) (Fig. 2A). Fig. 3 shows the values of the AUC after backward elimination. All 16 independent variables were entered into the analysis first and each variable was eliminated one by one. The maximal AUC was 0.672 (95% CI, 0.637–0.706; P < 0.001) (Fig. 2B), including the following 13 variables: the diameter of MPD, BMI, serum albumin, amount of intraoperative fluid infusion, age, preoperative platelet count, tumor location, portal vein resection, coexisting pancreatitis, serum lipase, neoadjuvant radiotherapy, ASA PS classification, and sex.
Fig. 2

(A) The receiver operating characteristic (ROC) of the nomogram. Area under the curve (AUC) = 0.679, P < 0.001. (B) The ROC of the artificial intelligence predictor. AUC = 0.672, P < 0.001.

Fig. 3

The area under the curve (AUC) values with backward elimination.

DISCUSSION

In the absence of a standardized management protocol for POPF until now, early prediction and recognition are crucial to identify patients at high risk of POPF requiring careful observation [2]. A series of traditional risk scoring systems, such as the original fistula risk score (o-FRS) [5] and the alternative fistula risk score (a-FRS) [6], have been used. However, several studies performed external validation and the predictability varied with the study population [781112]. Therefore, our institution suggested new predictive models using nomograms and AI [910] and this study validated the predictability of the new platforms with an external cohort. The nomogram including 6 simple variables had an AUC value of 0.709 in the development process [9], and 0.679 in the external validation. A few other nomograms were recently proposed. Huang et al. [13] suggested a new nomogram with the following 3 variables: BMI, the diameter of MPD, and drain fluid amylase level (DFA) on postoperative day (POD) 1. The AUC value was 0.744 in the external validation. Another nomogram by Suzuki et al. [14] also included drain fluid lipase level on POD 1 and decreased rate of DFA, which was defined as a change in levels from POD 1 to 3. The accuracy of the nomogram was 0.810, as stated in the study. Compared to these recently developed nomograms, our nomogram showed limited predictive value in the external validation. The AUC value might have decreased in the process of external validation with highly heterogeneous data collected from different centers. But most of all, the predictive power of the variables in the nomogram could also be limited. Previous studies suggested that DFA is a strong predictive factor of POPF [1516], and DFA on POD 1 is currently widely accepted as an indicator for early drain removal after PD [17]. Considering that our nomogram is composed of only preoperative and intraoperative factors, updating the platform with DFA may improve the accuracy and predictability of the model. Machine learning is a branch of AI technology designed to enable rapid analytical model building. It has been used in various medical fields including surgery. As far as we know, we invented the first AI-based prediction model for CR-POPF. The most remarkable advantage of machine learning is that it can identify complex structures in high-dimensional data [18] and detect latent variables, which are not directly measured using conventional analytical methods [19]. The new AI model yielded the maximal AUC value of 0.74 with 16 variables, and in the external validation with backward elimination, the AUC was 0.672 with 13 variables. This value is acceptable but leaves considerable room for improvement. First, there were quite a few missing values in both development and validation cohorts. Despite attempts to handle missing data in deep learning [20], it remains the main obstacle to model development. Also, the AI model includes a few variables, which cannot be objectively measured. For example, coexisting pancreatitis or pancreatic texture detected by surgeons intraoperatively can be highly subjective. In order to resolve this issue, several studies are underway to objectively measure those variables using preoperative images and machine learning [2122]. These efforts are expected to establish a foothold for improving predictability of the platforms in the future. The current study has several limitations. Since this study is based on retrospectively reviewed multicenter datasets, the results might have been affected by selection and information bias. Some potential factors that could influence the development of POPF, such as anastomosis technique and postoperative drain management, varied considerably among the surgeons and the institutions. Also, as previously stated, the platforms were developed and validated with datasets including missing values, which reduces the sample representativeness and complicates the analysis. Further studies with prospectively collected high-quality data are needed to upgrade the platforms with improved predictability. In conclusion, this study was performed to externally validate the previously developed prediction platforms for POPF. The results suggest the need for improvement and future studies to build better prediction models with higher accuracy.
  22 in total

1.  The theoretical status of latent variables.

Authors:  Denny Borsboom; Gideon J Mellenbergh; Jaap van Heerden
Journal:  Psychol Rev       Date:  2003-04       Impact factor: 8.934

2.  Nomogram for predicting postoperative pancreatic fistula.

Authors:  Yunghun You; In W Han; Dong W Choi; Jin S Heo; Youngju Ryu; Dae J Park; Seong H Choi; Sunjong Han
Journal:  HPB (Oxford)       Date:  2019-04-11       Impact factor: 3.647

3.  Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019.

Authors:  Emmanuel Melloul; Kristoffer Lassen; Didier Roulin; Fabian Grass; Julie Perinel; Mustapha Adham; Erik Björn Wellge; Filipe Kunzler; Marc G Besselink; Horacio Asbun; Michael J Scott; Cornelis H C Dejong; Dionisos Vrochides; Thomas Aloia; Jakob R Izbicki; Nicolas Demartines
Journal:  World J Surg       Date:  2020-07       Impact factor: 3.352

4.  Development and Validation of a New Nomogram for Predicting Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy.

Authors:  Xi-Tai Huang; Chen-Song Huang; Chen Liu; Wei Chen; Jian-Peng Cai; He Cheng; Xing-Xing Jiang; Li-Jian Liang; Xian-Jun Yu; Xiao-Yu Yin
Journal:  World J Surg       Date:  2020-09-08       Impact factor: 3.352

5.  Systematic review and meta-analysis of postoperative pancreatic fistula rates using the updated 2016 International Study Group Pancreatic Fistula definition in patients undergoing pancreatic resection with soft and hard pancreatic texture.

Authors:  Dilmurodjon Eshmuminov; Marcel A Schneider; Christoph Tschuor; Dimitri A Raptis; Patryk Kambakamba; Xavier Muller; Mickaël Lesurtel; Pierre-Alain Clavien
Journal:  HPB (Oxford)       Date:  2018-05-26       Impact factor: 3.647

6.  Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients.

Authors:  Enrico Molinari; Claudio Bassi; Roberto Salvia; Giovanni Butturini; Stefano Crippa; Giorgio Talamini; Massimo Falconi; Paolo Pederzoli
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

7.  Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation.

Authors:  Timothy H Mungroop; L Bengt van Rijssen; David van Klaveren; F Jasmijn Smits; Victor van Woerden; Ralph J Linnemann; Matteo de Pastena; Sjors Klompmaker; Giovanni Marchegiani; Brett L Ecker; Susan van Dieren; Bert Bonsing; Olivier R Busch; Ronald M van Dam; Joris Erdmann; Casper H van Eijck; Michael F Gerhards; Harry van Goor; Erwin van der Harst; Ignace H de Hingh; Koert P de Jong; Geert Kazemier; Misha Luyer; Awad Shamali; Salvatore Barbaro; Thomas Armstrong; Arjun Takhar; Zaed Hamady; Joost Klaase; Daan J Lips; I Quintus Molenaar; Vincent B Nieuwenhuijs; Coen Rupert; Hjalmar C van Santvoort; Joris J Scheepers; George P van der Schelling; Claudio Bassi; Charles M Vollmer; Ewout W Steyerberg; Mohammed Abu Hilal; Bas Groot Koerkamp; Marc G Besselink
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

8.  Clinical validation of scoring systems of postoperative pancreatic fistula after pancreatoduodenectomy: applicability to Eastern cohorts?

Authors:  Jae Seung Kang; Taesung Park; Youngmin Han; Seungyeon Lee; Jae Ri Kim; Hongbeom Kim; Wooil Kwon; Sun-Whe Kim; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi; Song Cheol Kim; Tae Ho Hong; Dong Sup Yoon; Joon Seong Park; Sang Jae Park; Sung-Sik Han; Sae-Byeol Choi; Joo Seop Kim; Chang-Sup Lim; Jin-Young Jang
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

9.  Validation of original and alternative fistula risk scores in postoperative pancreatic fistula.

Authors:  Youngju Ryu; Sang Hyun Shin; Dae Joon Park; Naru Kim; Jin Seok Heo; Dong Wook Choi; In Woong Han
Journal:  J Hepatobiliary Pancreat Sci       Date:  2019-07-01       Impact factor: 7.027

Review 10.  A Review of Integrative Imputation for Multi-Omics Datasets.

Authors:  Meng Song; Jonathan Greenbaum; Joseph Luttrell; Weihua Zhou; Chong Wu; Hui Shen; Ping Gong; Chaoyang Zhang; Hong-Wen Deng
Journal:  Front Genet       Date:  2020-10-15       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.